Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion

被引:52
作者
Forconi, Francesco [1 ]
Rinaldi, Andrea [2 ]
Kwee, Ivo [2 ,3 ]
Sozzi, Elisa [1 ]
Raspadori, Donatella [1 ]
Rancoita, Paola M. V. [2 ,3 ]
Scandurra, Marta [2 ]
Rossi, Davide [4 ,5 ]
Deambrogi, Clara [4 ,5 ]
Capello, Daniela [4 ,5 ]
Zucca, Emanuele [6 ]
Marconi, Daniela [5 ,7 ]
Bomben, Riccardo [7 ]
Gattei, Valter
Lauria, Francesco [1 ]
Gaidano, Gianluca [4 ,5 ]
Bertoni, Francesco [2 ]
机构
[1] Univ Siena, Dipartimento Med Clin & Sci Immunol, Sez Ematol & Trapianti, I-53100 Siena, Italy
[2] Oncol Inst So Switzerland, Expt Oncol Lab, Bellinzona, Switzerland
[3] Ist Dalle Molle Studi Intelligenza Artificiale, Manno, Switzerland
[4] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Genet Clin & Sperimentale, Div Ematol, Novara, Italy
[5] Univ Piemonte Orientale Amedeo Avogadro, BRMA, Novara, Italy
[6] Oncol Inst So Switzerland, Lymphoma Unit, Bellinzona, Switzerland
[7] IRCCS, Ctr Riferimento Oncol, Clin & Expt Oncohematol Unit, Aviano, PN, Italy
基金
瑞士国家科学基金会;
关键词
chronic lymphocytic leukaemia; 17p13; deletion; TP53; genome-wide DNA profile; 250K Affymetrix; single nucleotide polymporphysms;
D O I
10.1111/j.1365-2141.2008.07373.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Deletion of 17p (TP53) identifies a rare subset of chronic lymphocytic leukaemia (17p- CLL) with aggressive behaviour. Genome-wide DNA-profiling was performed to investigate 18 patients with 17p- CLL. All cases had multiple copy-number (CN) changes. Among the several recurrent CN changes identified, 8q24.13-q24.1-gain (MYC), 8p-loss (TNFRSF10A/B, also known as TRAIL1/2) and 2p16.1-p14-gain (REL/BCL11A) appeared frequently represented. 8p-loss and 2p16.1-p14-gain also appeared clinically relevant and predicted significant shorter time from diagnosis to treatment (8p-loss) and overall survival (8p-loss and 2p16.1-p14-gain, P < 0.05). These observations document a highly unstable genome in 17p- CLL and suggest that additional genes outside the TP53 locus may be important for tumour behaviour.
引用
收藏
页码:532 / 536
页数:5
相关论文
共 15 条
  • [1] A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon
    Fellermann, Klaus
    Stange, Daniel E.
    Schaeffeler, Elke
    Schmalzl, Hartmut
    Wehkamp, Jan
    Bevins, Charles L.
    Reinisch, Walter
    Teml, Alexander
    Schwab, Matthias
    Lichter, Peter
    Radlwimmer, Bernhard
    Stange, Eduard F.
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2006, 79 (03) : 439 - 448
  • [2] Loss of TP53 is due to rearrangements involving chromosome region 17p10∼p12 in chronic lymphocytic leukemia
    Fink, Stephanie R.
    Smoley, Stephanie A.
    Stockero, Kimberly J.
    Paternoster, Sarah F.
    Thorland, Erik C.
    Van Dyke, Daniel L.
    Shanafelt, Tait D.
    Zent, Clive S.
    Call, Timothy G.
    Kay, Neil E.
    Dewald, Gordon W.
    [J]. CANCER GENETICS AND CYTOGENETICS, 2006, 167 (02) : 177 - 181
  • [3] High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia
    Forconi, Francesco
    Poretti, Giulia
    Kwee, Ivo
    Sozzi, Elisa
    Rossi, Davide
    Rancoita, Paola M. V.
    Capello, Daniela
    Rinaldi, Andrea
    Zucca, Emanuele
    Raspadori, Donatella
    Spina, Valeria
    Lauria, Francesco
    Gaidano, Gianluca
    Bertoni, Francesco
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 (05) : 622 - 630
  • [4] Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
    Fukuhara, Noriko
    Tagawa, Hiroyuki
    Kameoka, Yoshihiro
    Kasugai, Yumiko
    Karnan, Sivasundaram
    Kameoka, Junichi
    Sasaki, Takeshi
    Morishima, Yasuo
    Nakamura, Shigeo
    Seto, Masao
    [J]. CANCER SCIENCE, 2006, 97 (06): : 499 - 504
  • [5] Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes
    Kienle, DL
    Korz, C
    Hosch, B
    Benner, A
    Mertens, D
    Habermann, A
    Kröber, A
    Jädger, U
    Lichter, P
    Döhner, H
    Stilgenbauer, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 3780 - 3792
  • [6] VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia
    Kröber, A
    Seiler, T
    Benner, A
    Bullinger, L
    Brückle, E
    Lichter, P
    Döhner, H
    Stilgenbauer, S
    [J]. BLOOD, 2002, 100 (04) : 1410 - 1416
  • [7] Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma
    Martinez-Climent, JA
    Vizcarra, E
    Sanchez, D
    Blesa, D
    Marugan, I
    Benet, I
    Sole, F
    Rubio-Moscardo, F
    Terol, MJ
    Climent, J
    Sarsotti, E
    Tormo, M
    Andreu, E
    Salido, M
    Ruiz, MA
    Prosper, F
    Siebert, R
    Dyer, MJS
    García-Conde, J
    [J]. BLOOD, 2001, 98 (12) : 3479 - 3482
  • [8] Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays
    Pfeifer, Dietmar
    Pantic, Milena
    Skatulla, Ilona
    Rawluk, Justyna
    Kreutz, Clemens
    Martens, Uwe M.
    Fisch, Paul
    Timmer, Jens
    Veelken, Hendrik
    [J]. BLOOD, 2007, 109 (03) : 1202 - 1210
  • [9] Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia
    Raval, Aparna
    Tanner, Stephan M.
    Byrd, John C.
    Angerman, Elizabeth B.
    Perko, James D.
    Chen, Shih-Shih
    Hackanson, Bjoern
    Grever, Michael R.
    Lucas, David M.
    MatkoviC, Jennifer J.
    Lin, Thomas S.
    Kipps, Thomas J.
    Murray, Fiona
    Weisenburger, Dennis
    Sanger, Warren
    Lynch, Jane
    Watson, Patrice
    Jansen, Mary
    Yoshinaga, Yuko
    Rosenquist, Richard
    de Jong, Pieter J.
    Coggill, Penny
    Beck, Stephan
    Lynch, Henry
    de la Chapelle, Albert
    Plass, Christoph
    [J]. CELL, 2007, 129 (05) : 879 - 890
  • [10] Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma:: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes
    Rubio-Moscardo, F
    Blesa, D
    Mestre, C
    Siebert, R
    Balasas, T
    Benito, A
    Rosenwald, A
    Climent, J
    Martinez, JI
    Schilhabel, M
    Karran, EL
    Gesk, S
    Esteller, M
    deLeeuw, R
    Staudt, LM
    Fernandez-Luna, JL
    Pinkel, D
    Dyer, MJS
    Martinez-Climent, JA
    [J]. BLOOD, 2005, 106 (09) : 3214 - 3222